Yutaka Shima

Title(s)SRA 3, Pharmacology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A central master driver of psychosocial stress responses in the rat. Science. 2020 03 06; 367(6482):1105-1112. Kataoka N, Shima Y, Nakajima K, Nakamura K. PMID: 32139538.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    2. A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model. . 2020 02; 19(2):375-383. Machida Y, Nakagawa M, Matsunaga H, Yamaguchi M, Ogawara Y, Shima Y, Yamagata K, Katsumoto T, Hattori A, Itoh M, Seki T, Nishiya Y, Nakamura K, Suzuki K, Imaoka T, Baba D, Suzuki M, Sampetrean O, Saya H, Ichimura K, Kitabayashi I. PMID: 31727689.
      View in: PubMed   Mentions:
    3. A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. Cell. 2019 04 18; 177(3):572-586.e22. Lytle NK, Ferguson LP, Rajbhandari N, Gilroy K, Fox RG, Deshpande A, Schürch CM, Hamilton M, Robertson N, Lin W, Noel P, Wartenberg M, Zlobec I, Eichmann M, Galván JA, Karamitopoulou E, Gilderman T, Esparza LA, Shima Y, Spahn P, French R, Lewis NE, Fisch KM, Sasik R, Rosenthal SB, Kritzik M, Von Hoff D, Han H, Ideker T, Deshpande AJ, Lowy AM, Adams PD, Reya T. PMID: 30955884.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    4. MLL is essential for NUP98-HOXA9-induced leukemia. Leukemia. 2017 10; 31(10):2200-2210. Shima Y, Yumoto M, Katsumoto T, Kitabayashi I. PMID: 28210005.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    5. IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia. Cancer Res. 2015 May 15; 75(10):2005-16. Ogawara Y, Katsumoto T, Aikawa Y, Shima Y, Kagiyama Y, Soga T, Matsunaga H, Seki T, Araki K, Kitabayashi I. PMID: 25795706.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    6. Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells. Cancer Sci. 2015 Mar; 106(3):227-36. Aikawa Y, Yamagata K, Katsumoto T, Shima Y, Shino M, Stanley ER, Cleary ML, Akashi K, Tenen DG, Kitabayashi I. PMID: 25529853.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    7. PML-RARa and its phosphorylation regulate pml oligomerization and HIPK2 stability. Cancer Res. 2013 Jul 15; 73(14):4278-88. Shima Y, Honma Y, Kitabayashi I. PMID: 23722549.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    8. Deregulated transcription factors in leukemia. Int J Hematol. 2011 Aug; 94(2):134-141. Shima Y, Kitabayashi I. PMID: 21823042.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    9. PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. Mol Cell Biol. 2008 Dec; 28(23):7126-38. Shima Y, Shima T, Chiba T, Irimura T, Pandolfi PP, Kitabayashi I. PMID: 18809579.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    10. Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription. Oncogene. 2007 Nov 08; 26(51):7231-9. Li XL, Arai Y, Harada H, Shima Y, Yoshida H, Rokudai S, Aikawa Y, Kimura A, Kitabayashi I. PMID: 17533375.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    11. Inhibition of cellular adhesion in human umbilical vein endothelial cells by NF-kappaB inhibitor DHMEQ under flow. Oncol Res. 2005; 15(4):189-97. Ohno O, Shima Y, Ikeda Y, Sakurai K, Watanabe K, Kawai Y, Umezawa K. PMID: 17822279.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    12. Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice. Cancer Res. 2003 Jan 01; 63(1):107-10. Kikuchi E, Horiguchi Y, Nakashima J, Kuroda K, Oya M, Ohigashi T, Takahashi N, Shima Y, Umezawa K, Murai M. PMID: 12517785.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    13. Selective growth inhibition by sangivamycin of human umbilical vein endothelial cells. Int J Oncol. 2001 May; 18(5):1009-15. Ohno O, Shima Y, Ikeda Y, Kondo SI, Kato K, Toi M, Umezawa K. PMID: 11295049.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells